bioRxiv: "Differential laboratory passaging of SARS-CoV-2 v…" - Qoto Mastodon

bioRxiv @biorxivpreprint@qoto.org

Differential laboratory passaging of SARS-CoV-2 viral stocks impacts the in vitro assessment of neutralizing antibodies https://www.biorxiv.org/content/10.1101/2023.07.14.549044v1?med=mas

Jul 15, 2023, 00:17 · · bioRxiv preprints · · ·

Sign in to participate in the conversation